These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34602732)

  • 1. C-kit, flt-3, PDGFR-β, and VEGFR2 expression in canine adrenal tumors and correlation with outcome following adrenalectomy.
    Harding K; De Mello Souza CH; Shiomitsu K; Maxwell E; Bertran J
    Can J Vet Res; 2021 Oct; 85(4):279-284. PubMed ID: 34602732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analysis of expression of VEGFR2, KIT, PDGFR-β, and CDK4 in canine urothelial carcinoma.
    Setyo LC; Donahoe SL; Shearer PL; Wang P; Krockenberger MB
    J Vet Diagn Invest; 2023 Mar; 35(2):109-115. PubMed ID: 36648148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of receptor tyrosine kinase targets PDGFR-β, VEGFR2 and KIT in canine transitional cell carcinoma.
    Walters L; Martin O; Price J; Sula MM
    Vet Comp Oncol; 2018 Mar; 16(1):E117-E122. PubMed ID: 28884928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemistry Screening of Different Tyrosine Kinase Receptors in Canine Solid Tumors-Part I: Proposal of a Receptor Panel to Predict Therapies.
    Dos Anjos DS; Civa PAS; Werner J; Vicente IST; Fonseca-Alves CE
    Int J Mol Sci; 2024 Aug; 25(15):. PubMed ID: 39126006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of expression and function of vascular endothelial growth factor receptor 2, platelet derived growth factor receptors-alpha and -beta, KIT, and RET in canine apocrine gland anal sac adenocarcinoma and thyroid carcinoma.
    Urie BK; Russell DS; Kisseberth WC; London CA
    BMC Vet Res; 2012 May; 8():67. PubMed ID: 22630170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor Tyrosine Kinase Expression Profiles in Canine Cutaneous and Subcutaneous Mast Cell Tumors.
    Thompson JJ; Morrison JA; Pearl DL; Boston SE; Wood GA; Foster RA; Coomber BL
    Vet Pathol; 2016 May; 53(3):545-58. PubMed ID: 26459517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PDGFR-α, PDGFR-β, VEGFR-2 and CD117 expression in canine mammary tumours and evaluation of the in vitro effects of toceranib phosphate in neoplastic mammary cell lines.
    Gattino F; Maniscalco L; Iussich S; Biasato I; Martano M; Morello E; Gola C; Millán Ruiz Y; Saeki N; Buracco P; Martín de Las Mulas J; De Maria R
    Vet Rec; 2018 Aug; 183(7):221. PubMed ID: 29440590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor tyrosine kinase expression and phosphorylation in canine nasal carcinoma.
    Hocker SE; Higginbotham ML; Schermerhorn T; Henningson J
    Res Vet Sci; 2017 Dec; 115():484-489. PubMed ID: 28783596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of PDGFR-β and Kit in canine anal sac apocrine gland adenocarcinoma using tissue immunohistochemistry.
    Brown RJ; Newman SJ; Durtschi DC; Leblanc AK
    Vet Comp Oncol; 2012 Mar; 10(1):74-9. PubMed ID: 22235855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Biomarkers Between Hepatic Tumors in Rat Models and a Dog.
    Kim S; Kim Y; Kim SE; Kim HJ
    In Vivo; 2023; 37(1):252-261. PubMed ID: 36593028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The three receptor tyrosine kinases c-KIT, VEGFR2 and PDGFRα, closely spaced at 4q12, show increased protein expression in triple-negative breast cancer.
    Jansson S; Bendahl PO; Grabau DA; Falck AK; Fernö M; Aaltonen K; Rydén L
    PLoS One; 2014; 9(7):e102176. PubMed ID: 25025175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of platelet-derived growth factor receptor-α/ß, vascular endothelial growth factor receptor-2, c-Abl, and c-Kit in canine granulomatous meningoencephalitis and necrotizing encephalitis.
    Song JH; Yu DH; Hwang TS; Seung BJ; Sur JH; Kim YJ; Jung DI
    Vet Med Sci; 2020 Nov; 6(4):965-974. PubMed ID: 32585777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis and angiogenic tyrosine kinase receptor expression in pediatric brain tumors.
    Virág J; Kenessey I; Haberler C; Piurkó V; Bálint K; Döme B; Tímár J; Garami M; Hegedűs B
    Pathol Oncol Res; 2014 Apr; 20(2):417-26. PubMed ID: 24190638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of VEGFR and PDGFR-α/-β in 187 canine nasal carcinomas.
    Gramer I; Killick D; Scase T; Chandry D; Marrington M; Blackwood L
    Vet Comp Oncol; 2017 Sep; 15(3):1041-1050. PubMed ID: 27278115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of platelet-derived growth factor and its receptors in spontaneous canine hemangiosarcoma and cutaneous hemangioma.
    Asa SA; Murai A; Murakami M; Hoshino Y; Mori T; Maruo K; Khater A; El-Sawak A; el-Aziz EA; Yanai T; Sakai H
    Histol Histopathol; 2012 May; 27(5):601-7. PubMed ID: 22419024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers.
    Wilczynski SP; Chen YY; Chen W; Howell SB; Shively JE; Alberts DS
    Hum Pathol; 2005 Mar; 36(3):242-9. PubMed ID: 15791568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiproliferative effects of masitinib and imatinib against canine oral fibrosarcoma in vitro.
    Milovancev M; Helfand SC; Marley K; Goodall CP; Löhr CV; Bracha S
    BMC Vet Res; 2016 Jun; 12():85. PubMed ID: 27259510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pheochromocytoma in Dogs Undergoing Adrenalectomy.
    Zini E; Nolli S; Ferri F; Massari F; Gerardi G; Nicoli S; Romanelli G; Montinaro V; Trez D; Cavicchioli L; Ferro S
    Vet Pathol; 2019 May; 56(3):358-368. PubMed ID: 30595108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of c-kit and platelet-derived growth factor receptors in ovarian granulosa cell tumors.
    Rocconi RP; Matthews KS; Kimball KJ; Conner MG; Baker AC; Barnes MN
    Reprod Sci; 2008 Sep; 15(7):673-7. PubMed ID: 18492696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The selective class III/V receptor tyrosine kinase inhibitor SU11657 inhibits tumor growth and angiogenesis in experimental neuroblastomas grown in mice.
    Bäckman U; Christofferson R
    Pediatr Res; 2005 May; 57(5 Pt 1):690-5. PubMed ID: 15718357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.